Evaluation of combination therapy with Statin and Ezetimible for patients with type II diabetes.

Not Applicable

• Conditions: Pateients with type II diabetes combined with dyslipidemia

• Registration Number: JPRN-UMIN000002261
• Lead Sponsor: Department of Cardiovascular Medicine, Saga University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-28
• Study Completion: 2015-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1) Pregnant and/or breathfeeding, child-bearing potential women during this study. 2) Past history of severe allergic reactions to ezetimibe 3) Renal dysfunctioned. (ALT>2 x Normal range of each institute) 4) Uncontrolled diabetes mellitus (HbA1c>=9%) 5) Renal insufficiency (serum creatinine>2.0mg/dL) 6) Heart failure, cardiac infarct, unstable angina, or stroke whithin 3 months. 7) Recieving insulin therapy 8) Secondary hyperlipidemia and/or drug-induced hyperlipidemia 9) Familial hyperlipidemia 10) otherwise, treating physician judged not to be appropriate for inclusion in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified